P. Muñiz

发表

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

I. Buño, J. Menárguez, C. Martínez-Laperche, 2022, BMC Cancer.

FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

I. Buño, J. Anguita, J. Díez-Martín, 2022, Cancers.

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations

I. Buño, S. Lois, M. Ballesteros, 2021, Cancers.

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

I. Buño, P. Font, J. Díez-Martín, 2021, Molecular oncology.

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2020, Genes.

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Menárguez, 2021, Frontiers in Immunology.

Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2023, Cancers.

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

I. Buño, J. Anguita, J. Díez-Martín, 2022, Frontiers in Immunology.

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms

I. Buño, M. Ballesteros, J. Anguita, 2019, Cancers.

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

I. Buño, P. Catalán, J. Triviño, 2022, Annals of Hematology.

Cell-Free DNA dynamic concentration and other variables are predictors of early progression after CAR T-Cell therapy in DLBCL patients.: cfDNA dynamics pre CAR-T in DLBCL.

I. Buño, J. Díez-Martín, F. Díaz-Crespo, 2023, Transplantation and cellular therapy.

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma

I. Buño, L. Sanz, J. Díez-Martín, 2021, Scientific Reports.

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2021, Frontiers in Immunology.

Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia

I. Buño, J. Anguita, J. Díez-Martín, 2020, Leukemia & lymphoma.